The Career of Greg T. Bolan

Greg T. Bolan’s status as a research analyst puts him in the higher echelon, primarily because he has so much strong experience. That is the primary rationale behind his most recent career choice, where assisted clients of Nashville boutique investment banking and asset management firm Avondale Partners. He served that firm well as a Senior Research Analyst with a specialty in Healthcare IT and Pharmaceutical Services. That position was in keeping with the rest of his career, as he has largely specialized in that area for 15 years.

Prior to Avondale, Greg T. Bolan spent considerable time with Sterne Agee’s Nashville office, where he helped to build an extremely skilled and knowledgeable team of healthcare analysts to examine such sub-sectors as Specialty Pharma, Managed Care and Medical Devices & Diagnostics. Before that, Greg also focused primarily on pharmaceutical companies with several other firms in Nashville and New York City. Greg T. Bolan also has a lot of education. After four years in the U.S. Army as an Infantry Rifleman and Squad Leader, Greg Bolan earned a Bachelor of Business Administration with a major in Finance from the Goizueta Business School at Atlanta’s Emory University.

Greg T. Bolan is currently the founder and senior portfolio manager at Star B Capital

Greg T. Bolan is currently the founder and senior portfolio manager at Star B Capital

Profile: Gregory Bolan, Avondale Partners

Currently, Greg Bolan serves his clients in his role a Senior Research Analyst at Avondale Partners, LLC, a boutique asset management and investment banking firm in Nashville. As he has been throughout his career, he is primarily focused on the healthcare and related sectors, and there is a reason for that. Over the course of a decade, Greg has been honing his skills as a researcher in the financial field and it is that experience that makes every investment decision he makes important. And his greatest success has been in the healthcare sector.

Prior to his time at Avondale Partners, Greg Bolan was the Managing Director of Healthcare Equity Research with the Nashville office of Sterne Agee. There, he was recognized as a No. 1 Stock Picker for Life Science Tools & Services by Starmine in 2014. That wasn’t the first time he was recognized for his skills, however. Back in 2010, he was recognized as the “Best Up & Comer” as part of Institutional Investor's All-American Research Team Survey in 2010. His vast experience also includes time as a Director of Healthcare Equity Research for Wells Fargo Securities and a stint as a Senior Associate of Healthcare Equity Research with Jefferies & Company.

Gregory Bolan, Avondale Partners

Currently, Greg Bolan can be found working as a Senior Research Analyst at Avondale Partners, LLC, a boutique investment banking and asset management firm in Nashville, Tennessee. There, he is primarily focused on the healthcare and targeted middle market sectors, and there is a reason for that. He has a lot of experience and education to back him up.

Following high school, Gregory Bolan served four years in the United States Army as an Infantry Rifleman and Squad Leader. After that, he earned a Bachelor of Business Administration with a major in Finance from Emory University’s Goizueta Business School in Atlanta. Over the course of the past decade, Greg has been honing his skills as a researcher in the financial field and it is that experience that makes every investment decision he makes special.

Before joining Avondale Partners, Greg was the Managing Director of Healthcare Equity Research with Sterne Agee in their Nashville office. There, he was recognized as a No. 1 Stock Picker for Life Science Tools & Services by Starmine in 2014. That wasn’t the first time he was recognized for his skills, however. Back in 2010, he was recognized as the “Best Up & Comer” as part of Institutional Investor's All-American Research Team Survey in 2010.

Gregory Bolan played a crucial role when it came to building an extremely skilled and knowledgeable team of healthcare analysts to examine such sub-sectors as Specialty Pharma, Managed Care and Medical Devices & Diagnostics. Greg's experience is vast and it includes time as a Director of Healthcare Equity Research for the Nashville office of Wells Fargo Securities, as well as stints as a Senior Associate of Healthcare Equity Research with Jefferies & Company in Nashville and as an Associate with a focus in healthcare at FNY GMG Capital in New York.

Gregory Bolan Profile

Gregory Bolan is a Senior Research Analyst covering Healthcare IT and Pharmaceutical Services with Avondale Partners, LLC, a boutique investment banking and asset management firm that is primarily focused on the healthcare and targeted middle market sectors. Over the last decade, he has been honing his skills as a gifted researcher in the financial field and that experience informs every investment decision he makes these days.

His experience as a research analyst is stellar. Before joining Avondale Partners, Gregory was the Managing Director of Healthcare Equity Research with Sterne Agee. Working in that firm’s Nashville office, he focused primarily on pharmaceutical companies. It was there that he was recognized by Starmine as a No. 1 Stock Picker for Life Science Tools & Services. In addition to that honor, which he received in 2014, he was called the “Best Up & Comer” as part of Institutional Investor's All-American Research Team Survey in 2010. Gregory also played a crucial role when it came to building an extremely skilled and knowledgeable team of healthcare analysts to examine such sub-sectors as Specialty Pharma, Managed Care and Medical Devices & Diagnostics.

Gregory Bolan's experience also includes extensive time as a Director of Healthcare Equity Research for the Nashville office of Wells Fargo Securities, as well as stints as a Senior Associate of Healthcare Equity Research with Jefferies & Company in Nashville and as an Associate with a focus in healthcare at FNY GMG Capital, New York. During his time at all of these firms, his primary focus was on the buy side of the healthcare industry.